Automation Upgrade at Influenza Vaccine Manufacturing Facility

This retrofit and phased expansion of an existing biotechnology facility aimed to reduce costs by increasing efficiency, increasing yield, reducing waste and increasing process automation – including multiple interfaces with manufacturing.


  • Liverpool, North West England, UK


  • MedImmune

Project Value

  • 35 million CAD (£20 M)

Project Status

  • Completed